On the accuracy of a one-compartment approach for determination of drug terminal half-life

被引:3
|
作者
Berezhkovskiy, Leonid M. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
terminal half-life; steady state volume of distribution; terminal volume of distribution; clearance; mean residence time; blood flow; blood-plasma ratio; hepatic clearance; physiological model; pharmacikinetics; STEADY-STATE; PHYSIOLOGICAL-PARAMETERS; PHARMACOKINETICS; VOLUME; PREDICTION; CLEARANCE; BODY;
D O I
10.1002/jps.23565
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The drug terminal half-life (t1/2) is commonly predicted by a simplified one-compartment approach (t1/2 = ln 2Vss/CL), where Vss and CL are the steady-state volume of distribution and the total body clearance of drug, respectively. The analysis of the accuracy of this approach is provided. It turns out that most often a simplified one-compartment calculation underestimates t1/2 by no more than 25% for human, 26% for dog, 20% for monkey, 19% for rat, and 23% for mouse. Thus, the application of a one-compartment calculation of t1/2 is well justifiable, except for the rare cases of very high drug clearance (@@@@), where r is the equilibrium blood-plasma concentration ratio, and Q is the cardiac output. (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:2082-2084, 2013
引用
收藏
页码:2082 / 2084
页数:3
相关论文
共 45 条
  • [1] Prediction of drug terminal half-life and terminal volume of distribution after intravenous dosing based on drug clearance, steady-state volume of distribution, and physiological parameters of the body
    Berezhkovskiy, Leonid M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (02) : 761 - 771
  • [2] An estimation method of the half-life for a one-compartment model of a single bolus intravenous injection by a single sampling
    Funatogawa, Takashi
    Funatogawa, Ikuko
    Yafune, Akifumi
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2007, 17 (05) : 827 - 837
  • [3] How Improved Sensitivity of Bioassays and Terminal Half-Life of Drugs Impact on Bioequivalence Trials
    Marzo, Antonio
    Fontana, Elena
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2009, 59 (01): : 55 - 58
  • [4] Strategy for Extending Half-life in Drug Design and Its Significance
    Gunaydin, Hakan
    Altman, Michael D.
    Ellis, J. Michael
    Fuller, Peter
    Johnson, Scott A.
    Lahue, Brian
    Lapointe, Blair
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (06): : 528 - 533
  • [5] Predicting human half-life for insulin analogs: An inter-drug approach
    Bendtsen, Kristian M.
    Harder, Magnus W. H.
    Glendorf, Tine
    Kjeldsen, Thomas B.
    Kristensen, Niels R.
    Refsgaard, Hanne H. F.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 201
  • [6] Relevance of Half-Life in Drug Design
    Smith, Dennis A.
    Beaumont, Kevin
    Maurer, Tristan S.
    Di, Li
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (10) : 4273 - 4282
  • [7] Prediction of the Vitreal Half-Life of Small Molecular Drug-Like Compounds
    Kidron, Heidi
    del Amo, Eva M.
    Vellonen, Kati-Sisko
    Urtti, Arto
    PHARMACEUTICAL RESEARCH, 2012, 29 (12) : 3302 - 3311
  • [8] A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates
    Chelle, Pierre
    Iorio, Alfonso
    Edginton, Andrea N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (09) : 2012 - 2021
  • [9] Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia
    Versloot, Olav
    Iserman, Emma
    Chelle, Pierre
    Germini, Federico
    Edginton, Andrea N.
    Schutgens, Roger E. G.
    Iorio, Alfonso
    Fischer, Kathelijn
    HEMASPHERE, 2022, 6 (04): : E694
  • [10] A New Pharmacokinetic Approach for a Better Understanding of the Relationship Between the Terminal Half-Life of Drug and Its Physiologically Based Pharmacokinetic Parameters
    Kwon, Younggil
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 109 (03) : 1421 - 1423